Jul 12, 2026 · 54 min · 12 segments
In this episode of *Communicable*, Angela Huttner and Josh Davis are joined by Brett Mitchell, Aline Wolfensberger and Lauren Clack to discuss the HAPPEN trial to prevent hospital-acquired pneumonia…
Brett MitchellGuest
Lauren ClackGuest
Aline WolfensbergerGuest
Angela HuttnerHost
Josh DavisHost
Hello, and welcome back to Communicable, the podcast brought to you by CMI Communications, Eskmit's open access journal covering infectious diseases and clinical microbiology.

and I'm the editor-in-chief of CMI Communications and an infectious diseases physician and clinical trialist based at the Geneva University Hospital in Switzerland.

I'm joined by my co-host, Josh Davis, infectious diseases physician and clinical trialist based at John Hunter Hospital and the University of Newcastle in Newcastle, Australia.

Today we're excited to be joined by three guests who are experts in an area we've not really covered on this podcast before, and that's clinical trials in infection prevention and control.

We'll be discussing two recent trials on prevention of hospital-acquired pneumonia.

So the trials are the HAPN trial, which was presented at ESMID Global in Munich in April this year and just published in Lancet ID.

And then also a hybrid implementation effectiveness trial, which was performed at a hospital in Zurich.
Read the full transcript.
Create an account to read the whole episode, search across every transcript, and follow the shows you care about.

Hello, and welcome back to Communicable, the podcast brought to you by CMI Communications, Eskmit's open access journal covering infectious diseases and clinical microbiology.

and I'm the editor-in-chief of CMI Communications and an infectious diseases physician and clinical trialist based at the Geneva University Hospital in Switzerland.

I'm joined by my co-host, Josh Davis, infectious diseases physician and clinical trialist based at John Hunter Hospital and the University of Newcastle in Newcastle, Australia.

Today we're excited to be joined by three guests who are experts in an area we've not really covered on this podcast before, and that's clinical trials in infection prevention and control.

We'll be discussing two recent trials on prevention of hospital-acquired pneumonia.

So the trials are the HAPN trial, which was presented at ESMID Global in Munich in April this year and just published in Lancet ID.

And then also a hybrid implementation effectiveness trial, which was performed at a hospital in Zurich.